New-onset hyperglycemia and acute coronary syndrome: A systematic overview and meta-analysis

Current Diabetes Reviews

Volumn 6, Issue 2, 2010, Pages 102-110

  Aneeli, Fabio ^a   Verdecchia, Paolo ^a   Karthikeyan, Ganesan ^b   Mazzotta, Giovanni ^a   Del Pinto, Maurizio ^a   Repaci, Salvatore ^a   Gatteschi, Camillo ^a   Gentile, Giorgio ^c   Cavallini, Claudio ^a   Reboldi, Gianpaolo ^c  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Acute coronary syndrome; Diabetes; Meta analysis; New hyperglycemia; Prognosis

Indexed keywords

GLUCOSE;

ACUTE CORONARY SYNDROME; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MEDLINE; META ANALYSIS; MORTALITY; NEW ONSET OF HYPERGLYCEMIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES COMPLICATIONS; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; PATIENT ADMISSION; PROGNOSIS;

EID: 77950857078     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339910790909413     Document Type: Review

References (48)

1. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115: 114-126
2. Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003; 8: 2433-2441
3. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619
4. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890
5. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc 1994; 1: 447-458
6. Whitehead A. Estimating the treatment difference in an individual trial. In: Meta-analysis of controlled clinical trials. Chichester: John Wiley & Sons Ltd. 2002; pp. 23-50.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
8. Tobias A. Assessing the influences of a single study in metaanalysis. Stat Tech Bull 1999; 47: 15-17
9. Sutton AJ, Abrams KR, Jones DR, et al. Methods for meta-analysis in medical research. Wiley Series in Probability and Statistics, John Wiley & Sons Ltd: Chichester 2000.
10. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573
11. Stranders I, Diamant M, van Gelder RE, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164: 982-988
12. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-3086
13. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA 1975; 233: 807-809
14. Lewandowicz J, Komorovski JM, Gozlinski H. Metabolic disorders in myocardial infarction: changes of blood serum zinc, growth hormone, insulin and glucose concentration in patients with acute myocardial infarction. Cor Vasa 1979; 21: 305-316
15. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981; 246: 1690-1693
16. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986; 293: 917-922
17. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycaemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64: 885-888
18. Sewdarsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. QJM 1989; 71: 461-466
19. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In- hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14: 758-760
20. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-1754
21. Kosuge M, Kimura K, Kojima S, et al. Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 2005; 69: 375-379
22. Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR. Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev 2005; 13: 223-230
23. Shen X, Jia S, Li H. The influence of admission glucose on epicardial and microvascular flow after primary angioplasty. Chin Med J 2006; 119: 95-102.
24. Meisinger C, Hörmann A, Heier M, Kuch B, Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol 2006; 113: 229-235
25. Goldberg RJ, Kramer DG, Lessard D, Yarzebski J, Gore JM. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis 2007; 18: 125-131
26. Gasior M, Pres D, Stasik-Pres G, et al. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 2008; 15: 422-430
27. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754-760
28. Ishihara M, Kagawa E, Inoue I, et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007; 99: 1674-1679
29. Petursson P, Herlitz J, Caidahl K, et al. Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 2007; 116: 315-320
30. Aguilar D, Solomon SD, Keber L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the Valsartan in Acute myocardial infarction (VALIANT) trial. Circulation 2004; 110: 1572-1578
31. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 2005; 22: 1321-1325
32. Timmer JR, van der Horst IC, Ottervanger JP, et al. Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004; 148: 399-404.
33. Scott AR, Cheng A,Greenacre M, Devlin G. Implications of hyper- glycaemia and ethnicity in patients with acute coronary syndromes in New Zealand. Diabetes Obes Metab 2007; 9: 121-126
34. Schiele F, Descotes-Genon V, Seronde MF, et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med 2006; 23: 1370-1376
35. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hypergly- caemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778
36. Worthley MI, Holmes AS, Willoughby SR, et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 2007; 49: 304-310
37. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hy- perglycemia in a NF-kB-dependent fashion. J Clin Invest 1998; 101: 1905-1915
38. Ray KK, Cannon CP, Morrow DA, et al. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 2007; 28: 806-813
39. Oliver MF. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med 2002; 112: 305-311
40. Iijima R, Nakajima R, Sugi K, Nakamura M. Improvement of postprandial hyperglycemia has a positive impact on epicardial flow of entire coronary tree in acute coronary syndromes patients. Circ J 2007; 71: 1079-1085
41. Pinto DS, Kirtane AJ, Pride YB, et al. CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 2008; 101: 303-307
42. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Anti- inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes. Rev Cardiovasc Med 2006; 7: S25-S34.
43. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Effect of hyperglycemia and insulin in acute coronary syndromes. Am J Cardiol 2007; 99: 12H-8H.
44. Mehta SR, Yusuf S, Diaz R, et al. CREATE-ECLA Trial Group. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437-446
45. Malmberg K, DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512-1515
46. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin- Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632
47. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650-661
48. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297